Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ev, LD; Schapoval, EES
   Microbiological assay for determination of ofloxacin injection
   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
   
   L.D. Ev e E.E.S. Schapoval, "Microbiological assay for determination of ofloxacin injection", J PHARM B, 27(1-2), 2002, pp. 91-96
2. Azcurra, AI; Yudi, LM; Baruzzi, AM; Kakiuchi, T
   Interfacial behavior of ofloxacin-Fe(III) complex at the water vertical bar 1,2-dichloroethane interface: a voltfluorometric and chronofluorometric study
   JOURNAL OF ELECTROANALYTICAL CHEMISTRY
   
   A.I. Azcurra et al., "Interfacial behavior of ofloxacin-Fe(III) complex at the water vertical bar 1,2-dichloroethane interface: a voltfluorometric and chronofluorometric study", J ELEC CHEM, 506(2), 2001, pp. 138-142
3. Gelatt, KN; van der Woerdt, A; Ketring, KL; Andrew, SE; Brooks, DE; Biros, DJ; Denis, HM; Cutler, TJ
   Enrofloxacin-associated retinal degeneration in cats
   VETERINARY OPHTHALMOLOGY
   
   K.N. Gelatt et al., "Enrofloxacin-associated retinal degeneration in cats", VET OPHTHAL, 4(2), 2001, pp. 99-106
4. Cekic, O; Batman, C; Yasar, U; Totan, Y; Basci, NE; Bozkurt, A; Zilelioglu, O; Kayaalp, SO
   Comparison of subretinal fluid levels of two 0.3% ciprofloxacin-containingeye drops
   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
   
   O. Cekic et al., "Comparison of subretinal fluid levels of two 0.3% ciprofloxacin-containingeye drops", CLIN EXP OP, 29(1), 2001, pp. 30-32
5. Immanuel, C; Kumar, AKH
   Simple and rapid high-performance liquid chromatography method for the determination of ofloxacin concentrations in plasma and urine
   JOURNAL OF CHROMATOGRAPHY B
   
   C. Immanuel e A.K.H. Kumar, "Simple and rapid high-performance liquid chromatography method for the determination of ofloxacin concentrations in plasma and urine", J CHROMAT B, 760(1), 2001, pp. 91-95
6. Maraschiello, C; Cusido, E; Abellan, M; Vilageliu, J
   Validation of an analytical procedure for the determination of the fluoroquinolone ofloxacin in chicken tissues
   JOURNAL OF CHROMATOGRAPHY B
   
   C. Maraschiello et al., "Validation of an analytical procedure for the determination of the fluoroquinolone ofloxacin in chicken tissues", J CHROMAT B, 754(2), 2001, pp. 311-318
7. Horstkotter, C; Blaschke, G
   Stereoselective determination of ofloxacin and its metabolites in human urine by capillary electrophoresis using laser-induced fluorescence detection
   JOURNAL OF CHROMATOGRAPHY B
   
   C. Horstkotter e G. Blaschke, "Stereoselective determination of ofloxacin and its metabolites in human urine by capillary electrophoresis using laser-induced fluorescence detection", J CHROMAT B, 754(1), 2001, pp. 169-178
8. Krizkova, L; Durackova, Z; Sandula, J; Sasinkova, V; Krajcovic, J
   Antioxidative and antimutagenic activity of yeast cell wall mannans in vitro
   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
   
   L. Krizkova et al., "Antioxidative and antimutagenic activity of yeast cell wall mannans in vitro", MUT RES-GTE, 497(1-2), 2001, pp. 213-222
9. Beumer, JH; Bosman, IJ; Maes, R
   Hair as a biological specimen for therapeutic drug monitoring
   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
   
   J.H. Beumer et al., "Hair as a biological specimen for therapeutic drug monitoring", INT J CL PR, 55(6), 2001, pp. 353-357
10. Alvarez-Lueje, A; Lopez, C; Nunez-Vergara, LJ; Squella, JA
    Voltammetric behavior and analytical applications of lomefloxacin, an antibacterial fluorquinolone
    JOURNAL OF AOAC INTERNATIONAL
    
    A. Alvarez-Lueje et al., "Voltammetric behavior and analytical applications of lomefloxacin, an antibacterial fluorquinolone", J AOAC INT, 84(3), 2001, pp. 649-658
11. Melde, SL
    Ofloxacin: A probable cause of toxic epidermal necrolysis
    ANNALS OF PHARMACOTHERAPY
    
    S.L. Melde, "Ofloxacin: A probable cause of toxic epidermal necrolysis", ANN PHARMAC, 35(11), 2001, pp. 1388-1390
12. Kushner, JM; Peckman, HJ; Snyder, CR
    Seizures associated with fluoroquinolones
    ANNALS OF PHARMACOTHERAPY
    
    J.M. Kushner et al., "Seizures associated with fluoroquinolones", ANN PHARMAC, 35(10), 2001, pp. 1194-1198
13. Scotton, PG; Pea, F; Giobbia, M; Baraldo, M; Vaglia, A; Furlanut, M
    Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis
    CLINICAL INFECTIOUS DISEASES
    
    P.G. Scotton et al., "Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis", CLIN INF D, 33(9), 2001, pp. E109-E111
14. Cheong, HJ; Yoo, CW; Sohn, JW; Kim, WJ; Kim, MJ; Park, SC
    Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea
    CLINICAL INFECTIOUS DISEASES
    
    H.J. Cheong et al., "Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea", CLIN INF D, 33(1), 2001, pp. 48-53
15. de los Reyes, MRA; Pato-Mesola, V; Klausner, JD; Manalastas, R; Wi, T; Tuazon, CU; Dallabetta, G; Whittington, WLH; Holmes, KK
    A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in the Philippines
    CLINICAL INFECTIOUS DISEASES
    
    M.R.A. de los Reyes et al., "A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in the Philippines", CLIN INF D, 32(9), 2001, pp. 1313-1318
16. Shenep, JL; Flynn, PM; Baker, DK; Hetherington, SV; Hudson, MM; Hughes, WT; Patrick, CC; Roberson, PK; Sandlund, JT; Santana, VM; Sixbey, JW; Slobod, KS
    Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer
    CLINICAL INFECTIOUS DISEASES
    
    J.L. Shenep et al., "Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer", CLIN INF D, 32(1), 2001, pp. 36-43
17. Grimaldo, ER; Tupasi, TE; Rivera, AB; Quelapio, MID; Cardano, RC; Derilo, JO; Belen, VA
    Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistantMycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    
    E.R. Grimaldo et al., "Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistantMycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines", INT J TUBE, 5(6), 2001, pp. 546-550
18. Chierakul, N; Klomsawat, D; Chulavatnatol, S; Chindavijak, B
    Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    
    N. Chierakul et al., "Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis", INT J TUBE, 5(3), 2001, pp. 278-282
19. Ross, J
    Extracts from "Clinical Evidence" - Pelvic inflammatory disease
    BRITISH MEDICAL JOURNAL
    
    J. Ross, "Extracts from "Clinical Evidence" - Pelvic inflammatory disease", BR MED J, 322(7287), 2001, pp. 658-659
20. Belicova, A; Ebringer, L; Krajcovic, J; Hromadkova, Z; Ebringerova, A
    Antimutagenic effect of heteroxylans, arabinogalactans, pectins and mannans in the Euglena assay
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
    
    A. Belicova et al., "Antimutagenic effect of heteroxylans, arabinogalactans, pectins and mannans in the Euglena assay", WORLD J MIC, 17(3), 2001, pp. 293-299
21. Ross, JDC
    European guideline for the management of pelvic inflammatory disease and perihepatitis
    INTERNATIONAL JOURNAL OF STD & AIDS
    
    J.D.C. Ross, "European guideline for the management of pelvic inflammatory disease and perihepatitis", INT J STD A, 12, 2001, pp. 84-87
22. Chen, J; Chen, RRL; Huang, HS
    Comparison of ofloxacin and norfloxacin concentration in prostatic tissuesin patients undergoing transurethral resection of the prostate
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    
    J. Chen et al., "Comparison of ofloxacin and norfloxacin concentration in prostatic tissuesin patients undergoing transurethral resection of the prostate", J FORMOS ME, 100(8), 2001, pp. 548-552
23. van der Linden, PD; Nab, HW; Simonian, S; Stricker, BHC; Leufkens, HGM; Herings, RMC
    Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands
    PHARMACY WORLD & SCIENCE
    
    P.D. van der Linden et al., "Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands", PHARM WORLD, 23(3), 2001, pp. 89-92
24. Sambatakou, H; Giamarellos-Bourboulis, EJ; Galanakis, N; Giamarellou, H
    Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    H. Sambatakou et al., "Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid", INT J ANT A, 18(5), 2001, pp. 441-444
25. Von Baum, H; Bottcher, S; Abel, R; Gerner, HJ; Sonntag, HG
    Tissue and serum concentrations of levofloxacin in orthopaedic patients
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    H. Von Baum et al., "Tissue and serum concentrations of levofloxacin in orthopaedic patients", INT J ANT A, 18(4), 2001, pp. 335-340
26. Ives, TJ; Marston, EL; Regnery, RL; Butts, JD
    In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    T.J. Ives et al., "In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers", INT J ANT A, 18(3), 2001, pp. 217-222
27. Dan, M; Poch, F; Asherov, J
    Crossover assessment of serum bactericidal activity of grepafloxacin, ofloxacin and clarithromycin against respiratory pathogens after oral administration to healthy volunteers
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    M. Dan et al., "Crossover assessment of serum bactericidal activity of grepafloxacin, ofloxacin and clarithromycin against respiratory pathogens after oral administration to healthy volunteers", INT J ANT A, 17(6), 2001, pp. 491-495
28. Reid, G; Habash, M; Vachon, D; Denstedt, J; Riddell, J; Beheshti, M
    Oral fluoroquinolone therapy results in drug adsorption on ureteral stentsand prevention of biofilm formation
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    G. Reid et al., "Oral fluoroquinolone therapy results in drug adsorption on ureteral stentsand prevention of biofilm formation", INT J ANT A, 17(4), 2001, pp. 317-320
29. Rodriguez, JC; Ruiz, M; Climent, A; Royo, G
    In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    J.C. Rodriguez et al., "In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis", INT J ANT A, 17(3), 2001, pp. 229-231
30. Dhople, AM
    In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    A.M. Dhople, "In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans", INT J ANT A, 17(1), 2001, pp. 57-61
31. Gieffers, J; Solbach, W; Maass, M
    In vitro susceptibility and eradication of chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells
    CARDIOVASCULAR DRUGS AND THERAPY
    
    J. Gieffers et al., "In vitro susceptibility and eradication of chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells", CARDIO DRUG, 15(3), 2001, pp. 259-262
32. Yabe, K; Murakami, Y; Nishida, S; Sekiguchi, M; Furuhama, K; Goryo, M; Okada, K
    A non-arthropathic dose and its disposition following repeated oral administration of ofloxacin, a new quinolone antimicrobial agent, to juvenile dogs
    JOURNAL OF VETERINARY MEDICAL SCIENCE
    
    K. Yabe et al., "A non-arthropathic dose and its disposition following repeated oral administration of ofloxacin, a new quinolone antimicrobial agent, to juvenile dogs", J VET MED S, 63(8), 2001, pp. 867-872
33. Myer, CM
    Historical perspective on the use of otic antimicrobial agents
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    C.M. Myer, "Historical perspective on the use of otic antimicrobial agents", PEDIAT INF, 20(1), 2001, pp. 98-101
34. Klein, JO
    In vitro and in vivo antimicrobial activity of topical ofloxacin and otherototopical agents
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    J.O. Klein, "In vitro and in vivo antimicrobial activity of topical ofloxacin and otherototopical agents", PEDIAT INF, 20(1), 2001, pp. 102-103
35. Ruben, RJ
    Efficacy of ofloxacin and other otic preparations for otitis externa
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    R.J. Ruben, "Efficacy of ofloxacin and other otic preparations for otitis externa", PEDIAT INF, 20(1), 2001, pp. 108-110
36. Bluestone, CD
    Efficacy of ofloxacin and other ototopical preparations for chronic suppurative otitis media in children
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    C.D. Bluestone, "Efficacy of ofloxacin and other ototopical preparations for chronic suppurative otitis media in children", PEDIAT INF, 20(1), 2001, pp. 111-115
37. Goldblatt, EL
    Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    E.L. Goldblatt, "Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes", PEDIAT INF, 20(1), 2001, pp. 116-119
38. Klein, JO; McCracken, GH
    Summary and conclusions
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    J.O. Klein e G.H. McCracken, "Summary and conclusions", PEDIAT INF, 20(1), 2001, pp. 123-125
39. Garcia-Saenz, MC; Arias-Puente, A; Fresnadillo-Martinez, MJ; Carrasco-Font, C
    Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY
    
    M.C. Garcia-Saenz et al., "Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin", J CAT REF S, 27(12), 2001, pp. 1969-1974
40. Bottcher, S; von Baum, H; Hoppe-Tichy, T; Benz, C; Sonntag, HG
    An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    S. Bottcher et al., "An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum", J PHARM B, 25(2), 2001, pp. 197-203
41. Di Colo, G; Burgalassi, S; Chetoni, P; Fiaschi, MP; Zambito, Y; Saettone, MF
    Relevance of polymer molecular weight to the in vitro/in vivo performancesof ocular inserts based on poly(ethylene oxide)
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    G. Di Colo et al., "Relevance of polymer molecular weight to the in vitro/in vivo performancesof ocular inserts based on poly(ethylene oxide)", INT J PHARM, 220(1-2), 2001, pp. 169-177
42. Di Colo, G; Burgalassi, S; Chetoni, P; Fiaschi, MP; Zambito, Y; Saettone, MF
    Gel-forming erodible inserts for ocular controlled delivery of ofloxacin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    G. Di Colo et al., "Gel-forming erodible inserts for ocular controlled delivery of ofloxacin", INT J PHARM, 215(1-2), 2001, pp. 101-111
43. Koester, LS; Guterres, SS; Le Roch, M; Eifler-Lima, VL; Zuanazzi, JA; Bassani, VL
    Ofloxacin/beta-cyclodextrin complexation
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    
    L.S. Koester et al., "Ofloxacin/beta-cyclodextrin complexation", DRUG DEV IN, 27(6), 2001, pp. 533-540
44. Thiel, R; Metzner, S; Gericke, C; Rahm, U; Stahlmann, R
    Effects of fluoroquinolones on the locomotor activity in rats
    ARCHIVES OF TOXICOLOGY
    
    R. Thiel et al., "Effects of fluoroquinolones on the locomotor activity in rats", ARCH TOXIC, 75(1), 2001, pp. 36-41
45. Stass, H; Schuhly, U; Moller, JG; Delesen, H
    Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel8-methoxyfluoroquinolone, in healthy volunteers
    CLINICAL PHARMACOKINETICS
    
    H. Stass et al., "Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel8-methoxyfluoroquinolone, in healthy volunteers", CLIN PHARMA, 40, 2001, pp. 49-55
46. Ji, BH
    Does there exist a subgroup of MB patients at greater risk of relapse after MDT?
    LEPROSY REVIEW
    
    B.H. Ji, "Does there exist a subgroup of MB patients at greater risk of relapse after MDT?", LEPROSY REV, 72(1), 2001, pp. 3-7
47. Lawrence, LE; Wu, P; Fan, L; Gouveia, KE; Card, A; Casperson, M; Denbleyker, K; Barrett, JF
    The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues
    Journal of antimicrobial chemotherapy
    
    L.E. Lawrence et al., "The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues", J ANTIMICRO, 48(2), 2001, pp. 195-201
48. Shirtliff, ME; Calhoun, JH; Mader, JT
    Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits
    Journal of antimicrobial chemotherapy
    
    M.E. Shirtliff et al., "Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits", J ANTIMICRO, 48(2), 2001, pp. 253-258
49. Drago, L; De Vecchi, E; Mombelli, B; Nicola, L; Valli, M; Gismondo, MR
    Activity of levofloxacin and ciprofloxacin against urinary pathogens
    Journal of antimicrobial chemotherapy
    
    L. Drago et al., "Activity of levofloxacin and ciprofloxacin against urinary pathogens", J ANTIMICRO, 48(1), 2001, pp. 37-45
50. Destache, CJ; Pakiz, CB; Larsen, C; Owens, H; Dash, AK
    Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in anexperimental rabbit meningitis model
    Journal of antimicrobial chemotherapy
    
    C.J. Destache et al., "Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in anexperimental rabbit meningitis model", J ANTIMICRO, 47(5), 2001, pp. 611-615
51. Sunderland, J; Tobin, CM; Hedges, AJ; MacGowan, AP; White, LO
    Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography
    Journal of antimicrobial chemotherapy
    
    J. Sunderland et al., "Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography", J ANTIMICRO, 47(3), 2001, pp. 271-275
52. Traunmuller, F; Thalhammer-Scherrer, R; Locker, GJ; Losert, H; Schmid, R; Staudinger, T; Thalhammer, F
    Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients
    Journal of antimicrobial chemotherapy
    
    F. Traunmuller et al., "Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients", J ANTIMICRO, 47(2), 2001, pp. 229-231
53. Dajcs, JJ; Moreau, JM; Thibodeaux, BA; Traidej, M; Austin, MS; Marquart, ME; Stroman, DW; O'Callaghan, RJ
    Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis
    CORNEA
    
    J.J. Dajcs et al., "Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis", CORNEA, 20(8), 2001, pp. 878-880
54. Kim, HS; Sah, WJ; Kim, YJ; Kim, JC; Hahn, TW
    Amniotic membrane, tear film, corneal, and aqueous levels of ofloxacin in rabbit eyes after amniotic membrane transplantation
    CORNEA
    
    H.S. Kim et al., "Amniotic membrane, tear film, corneal, and aqueous levels of ofloxacin in rabbit eyes after amniotic membrane transplantation", CORNEA, 20(6), 2001, pp. 628-634
55. Graves, A; Henry, M; O'Brien, TP; Hwang, DG; Van Buskirk, A; Trousdale, MD
    In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones
    CORNEA
    
    A. Graves et al., "In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones", CORNEA, 20(3), 2001, pp. 301-305
56. Kowalski, RP; Romanowski, EG; Yates, KA; Gordon, YJ
    Lomefloxacin is an effective treatment of experimental bacterial keratitis
    CORNEA
    
    R.P. Kowalski et al., "Lomefloxacin is an effective treatment of experimental bacterial keratitis", CORNEA, 20(3), 2001, pp. 306-308
57. Prajna, NV; George, C; Selvaraj, S; Lu, KL; McDonnell, PJ; Srinivasan, M
    Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis
    CORNEA
    
    N.V. Prajna et al., "Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis", CORNEA, 20(2), 2001, pp. 175-178
58. Ravnan, SL; Locke, C
    Levofloxacin and warfarin interaction
    PHARMACOTHERAPY
    
    S.L. Ravnan e C. Locke, "Levofloxacin and warfarin interaction", PHARMACOTHE, 21(7), 2001, pp. 884-885
59. Bertino, JS
    Integrating fluoroquinolones into the hospital formulary
    PHARMACOTHERAPY
    
    J.S. Bertino, "Integrating fluoroquinolones into the hospital formulary", PHARMACOTHE, 21(10), 2001, pp. 273S-283S
60. Dajcs, JJ; Moreau, JM; Stroman, DW; Schlech, BA; Ke, TL; Thibodeaux, BA; Girgis, DO; Caballero, AR; O'Callaghan, RJ
    The effectiveness of tobramycin and Ocuflox (R) in a prophylaxis model of Staphylococcus keratitis
    CURRENT EYE RESEARCH
    
    J.J. Dajcs et al., "The effectiveness of tobramycin and Ocuflox (R) in a prophylaxis model of Staphylococcus keratitis", CURR EYE R, 23(1), 2001, pp. 60-63
61. Xia, PY; Feng, P; Zhong, L; Lu, XJ; Lei, BJ
    Accumulation of ofloxacin and tosufloxacin in fluoroquinolone resistant E coli
    ACTA PHARMACOLOGICA SINICA
    
    P.Y. Xia et al., "Accumulation of ofloxacin and tosufloxacin in fluoroquinolone resistant E coli", ACT PHAR SI, 22(3), 2001, pp. 210-214
62. Amin, AS; Moustafa, ME; Dessouki, HA; Abd-Allah, A
    Complexation equilibria between antibacterial drugs and tungstate, molybdate and vanadate applied to their determination in pure and dosage forms
    QUIMICA ANALITICA
    
    A.S. Amin et al., "Complexation equilibria between antibacterial drugs and tungstate, molybdate and vanadate applied to their determination in pure and dosage forms", QUIM ANAL, 20(2), 2001, pp. 93-98
63. de Boer, T; Mol, R; de Zeeuw, RA; de Jong, GJ; Ensing, K
    Enantioseparation of ofloxacin in urine by capillary electrokinetic chromatography using charged cyclodextrins as chiral selectors and assessment of enantioconversion
    ELECTROPHORESIS
    
    T. de Boer et al., "Enantioseparation of ofloxacin in urine by capillary electrokinetic chromatography using charged cyclodextrins as chiral selectors and assessment of enantioconversion", ELECTROPHOR, 22(7), 2001, pp. 1413-1418
64. Srividya, B; Cardoza, RM; Amin, PD
    Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system
    JOURNAL OF CONTROLLED RELEASE
    
    B. Srividya et al., "Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system", J CONTR REL, 73(2-3), 2001, pp. 205-211
65. Macias, B; Villa, MV; Rubio, I; Castineiras, A; Borras, J
    Complexes of Ni(II) and Cu(II) with ofloxacin Crystal structure of a new Cu(II) ofloxacin complex
    JOURNAL OF INORGANIC BIOCHEMISTRY
    
    B. Macias et al., "Complexes of Ni(II) and Cu(II) with ofloxacin Crystal structure of a new Cu(II) ofloxacin complex", J INORG BIO, 84(3-4), 2001, pp. 163-170
66. Price, FW; Willes, L; Price, M; Lyng, A; Ries, J
    A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis
    OPHTHALMOLOGY
    
    F.W. Price et al., "A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis", OPHTHALMOL, 108(7), 2001, pp. 1236-1244
67. Lee, SY; Min, BH; Hwang, SH; Koo, YM; Lee, CK; Song, SW; Oh, SY; Lim, SM; Kim, SL; Kim, DI
    Enantioselective production of levofloxacin by immobilized porcine liver esterase
    BIOTECHNOLOGY LETTERS
    
    S.Y. Lee et al., "Enantioselective production of levofloxacin by immobilized porcine liver esterase", BIOTECH LET, 23(13), 2001, pp. 1033-1037
68. Rodriguez-Morales, A; Llamazares, AA; Benito, RP; Cocera, CM
    Fixed drug eruption from quinolones with a positive lesional patch test tociprofloxacin
    CONTACT DERMATITIS
    
    A. Rodriguez-Morales et al., "Fixed drug eruption from quinolones with a positive lesional patch test tociprofloxacin", CONTACT DER, 44(4), 2001, pp. 255-255
69. Kane, KY; Pierce, R
    What are the most effective treatments for bacterial vaginosis in nonpregnant women?
    JOURNAL OF FAMILY PRACTICE
    
    K.Y. Kane e R. Pierce, "What are the most effective treatments for bacterial vaginosis in nonpregnant women?", J FAM PRACT, 50(5), 2001, pp. 399-400
70. Holten, KB; Gick, J
    Management of the patient with otitis externa
    JOURNAL OF FAMILY PRACTICE
    
    K.B. Holten e J. Gick, "Management of the patient with otitis externa", J FAM PRACT, 50(4), 2001, pp. 353
71. Erden, BF; Ulak, E; Yildiz, F; Utkan, T; Ozdemirci, S; Gacar, N
    Antidepressant, anxiogenic, and antinociceptive properties of levofloxacinin rats and mice
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    B.F. Erden et al., "Antidepressant, anxiogenic, and antinociceptive properties of levofloxacinin rats and mice", PHARM BIO B, 68(3), 2001, pp. 435-441
72. Matsumoto, Y; Ikemoto, A; Wakai, Y; Ikeda, F; Tawara, S; Matsumo, K
    Mechanism of therapeutic effectiveness of cefixime against typhoid fever
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    Y. Matsumoto et al., "Mechanism of therapeutic effectiveness of cefixime against typhoid fever", ANTIM AG CH, 45(9), 2001, pp. 2450-2454
73. Tarshis, GA; Miskin, BM; Jones, TM; Champlin, J; Wingert, KJ; Breen, JD; Brown, MJ
    Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: Double-blind, multicenter, randomized study
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    G.A. Tarshis et al., "Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: Double-blind, multicenter, randomized study", ANTIM AG CH, 45(8), 2001, pp. 2358-2362
74. Gikas, A; Spyridaki, I; Scoulica, E; Psaroulaki, A; Tselentis, Y
    In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    A. Gikas et al., "In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin", ANTIM AG CH, 45(11), 2001, pp. 3276-3278
75. Aly, FA; Al-Tamimi, SA; Alwarthan, AA
    Chemiluminescence determination of some fluoroquinolone derivatives in pharmaceutical formulations and biological fluids using [Ru(bipy)(2)(+)(3)]-Ce(IV) system
    TALANTA
    
    F.A. Aly et al., "Chemiluminescence determination of some fluoroquinolone derivatives in pharmaceutical formulations and biological fluids using [Ru(bipy)(2)(+)(3)]-Ce(IV) system", TALANTA, 53(4), 2001, pp. 885-893
76. Kudo, M; Ohkubo, T; Sugawara, K
    Development of measurement of new quinolones in body fluids by HPLC using column switching and their application to drug interaction
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    
    M. Kudo et al., "Development of measurement of new quinolones in body fluids by HPLC using column switching and their application to drug interaction", YAKUGAKU ZA, 121(5), 2001, pp. 319-326
77. Ah-Tye, C; Paradise, JL; Colborn, DK
    Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: Prevalence, incidence, and duration
    PEDIATRICS
    
    C. Ah-Tye et al., "Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: Prevalence, incidence, and duration", PEDIATRICS, 107(6), 2001, pp. 1251-1258
78. Watanabe, K; Numata-Watanabe, K; Hayasaka, S
    Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas
    OPHTHALMIC RESEARCH
    
    K. Watanabe et al., "Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas", OPHTHAL RES, 33(3), 2001, pp. 136-139
79. Giannopoulos, A; Koratzanis, G; Giamarellos-Bourboulis, EJ; Panou, C; Adamakis, I; Giamarellou, H
    Pharmacokinetics of clarithromycin in the prostate: Implications for the treatment of chronic abacterial prostatitis
    JOURNAL OF UROLOGY
    
    A. Giannopoulos et al., "Pharmacokinetics of clarithromycin in the prostate: Implications for the treatment of chronic abacterial prostatitis", J UROL, 165(1), 2001, pp. 97-99
80. Anderson, ME; Mazur, A; Yang, T; Roden, DM
    Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.E. Anderson et al., "Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics", J PHARM EXP, 296(3), 2001, pp. 806-810
81. Robert, PY; Adenis, JP
    Comparative review of topical ophthalmic antibacterial preparations
    DRUGS
    
    P.Y. Robert e J.P. Adenis, "Comparative review of topical ophthalmic antibacterial preparations", DRUGS, 61(2), 2001, pp. 175-185
82. Berning, SE
    The role of fluoroquinolones in tuberculosis today
    DRUGS
    
    S.E. Berning, "The role of fluoroquinolones in tuberculosis today", DRUGS, 61(1), 2001, pp. 9-18
83. Yew, WW
    Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives
    CLINICA CHIMICA ACTA
    
    W.W. Yew, "Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives", CLIN CHIM A, 313(1-2), 2001, pp. 31-36
84. Bonfiglio, G; Scuderi, AC; Russo, G
    Netilmicin: In vitro activity, time-kill evaluation and postantibiotic effect on microorganisms isolated from ocular infections
    CHEMOTHERAPY
    
    G. Bonfiglio et al., "Netilmicin: In vitro activity, time-kill evaluation and postantibiotic effect on microorganisms isolated from ocular infections", CHEMOTHERA, 47(2), 2001, pp. 117-122
85. MacLeod, W
    Case report: Severe neurologic reaction to ciprofloxacin
    CANADIAN FAMILY PHYSICIAN
    
    W. MacLeod, "Case report: Severe neurologic reaction to ciprofloxacin", CAN FAM PHY, 47, 2001, pp. 553-555
86. Van der Linden, PD; van Puijenbroek, EP; Feenstra, J; in't Veld, BA; Sturkenboom, MCJM; Herings, RMC; Leufkens, HGM; Stricker, BHC
    Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneousreports in the period 1988 to 1998
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
    
    P.D. Van der Linden et al., "Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneousreports in the period 1988 to 1998", ARTH RH ART, 45(3), 2001, pp. 235-239
87. Lee, EJ; Yeo, JA; Jung, K; Hwangbo, HJ; Lee, GJ; Kim, SK
    Enantioselective binding of ofloxacin to B form DNA
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    
    E.J. Lee et al., "Enantioselective binding of ofloxacin to B form DNA", ARCH BIOCH, 395(1), 2001, pp. 21-24
88. Gupta, K; Hooton, TM; Roberts, PL; Stamm, WE
    Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women
    ANNALS OF INTERNAL MEDICINE
    
    K. Gupta et al., "Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women", ANN INT MED, 135(1), 2001, pp. 9-16
89. Davenport, CLM; Boston, RC; Richardson, DW
    Effects of enrofloxacin and magnesium deficiency on matrix metabolism in equine articular cartilage
    AMERICAN JOURNAL OF VETERINARY RESEARCH
    
    C.L.M. Davenport et al., "Effects of enrofloxacin and magnesium deficiency on matrix metabolism in equine articular cartilage", AM J VET RE, 62(2), 2001, pp. 160-166
90. Krizkova, L; Nagy, M; Polonyi, J; Dobias, J; Belicova, A; Grancai, D; Krajcovic, J
    Phenolic acids inhibit chloroplast mutagenesis in Euglena gracilis
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    
    L. Krizkova et al., "Phenolic acids inhibit chloroplast mutagenesis in Euglena gracilis", MUT RES-GTE, 469(1), 2000, pp. 107-114
91. Hegstad, S; Ingebrigtsen, K; Reistad, R; Paulsen, JE; Alexander, J
    Incorporation of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) into hair of mice
    BIOMARKERS
    
    S. Hegstad et al., "Incorporation of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) into hair of mice", BIOMARKERS, 5(1), 2000, pp. 24-32
92. Shobha, JC; Kumar, TR; Deivanayagam, N; Singh, RB; Waghray, P; Babu, PA; Bhaduri, J; Sekhar, CC
    Clinical evaluation of the tolerability and efficacy of trovafloxacin compared with sparfloxacin in the treatment of lower respiratory tract infections
    CLINICAL DRUG INVESTIGATION
    
    J.C. Shobha et al., "Clinical evaluation of the tolerability and efficacy of trovafloxacin compared with sparfloxacin in the treatment of lower respiratory tract infections", CLIN DRUG I, 20(2), 2000, pp. 95-100
93. Rittenhouse, BE; Stinnett, AA; Dulisse, B; Henke, CJ; Potter, L; Parasuraman, B; Martens, LL; Williams, RR; Kojak, C
    An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia
    AMERICAN JOURNAL OF MANAGED CARE
    
    B.E. Rittenhouse et al., "An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia", AM J M CARE, 6(3), 2000, pp. 381-389
94. Zhang, YP; Xu, QA; Trissel, LA; Williams, KY
    Compatibility and stability of linezolid injection admixed with three quinolone antibiotics
    ANNALS OF PHARMACOTHERAPY
    
    Y.P. Zhang et al., "Compatibility and stability of linezolid injection admixed with three quinolone antibiotics", ANN PHARMAC, 34(9), 2000, pp. 996-1001
95. Melvani, S; Speed, BR
    Alatrofloxacin-induced seizures during slow intravenous infusion
    ANNALS OF PHARMACOTHERAPY
    
    S. Melvani e B.R. Speed, "Alatrofloxacin-induced seizures during slow intravenous infusion", ANN PHARMAC, 34(9), 2000, pp. 1017-1019
96. Frenck, RW; Nakhla, I; Sultan, Y; Bassily, SB; Girgis, YF; David, J; Butler, TC; Girgis, NI; Morsy, M
    Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoidfever in children
    CLINICAL INFECTIOUS DISEASES
    
    R.W. Frenck et al., "Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoidfever in children", CLIN INF D, 31(5), 2000, pp. 1134-1138
97. Novack, GD
    Financing new drug development in ophthalmology
    JOURNAL OF GLAUCOMA
    
    G.D. Novack, "Financing new drug development in ophthalmology", J GLAUCOMA, 9(2), 2000, pp. 195-199
98. Abd-Allah, ARA; Gannam, BB; Hamada, FMA
    The impact of ofloxacin on rat testicular DNA: Application of image analysis
    PHARMACOLOGICAL RESEARCH
    
    A.R.A. Abd-Allah et al., "The impact of ofloxacin on rat testicular DNA: Application of image analysis", PHARMAC RES, 42(2), 2000, pp. 145-150
99. Abd-Allah, ARA; Aly, HAA; Moustafa, AMA; Abdel-Aziz, AAH; Hamada, FMA
    Adverse testicular effects of some quinolone members in rats
    PHARMACOLOGICAL RESEARCH
    
    A.R.A. Abd-Allah et al., "Adverse testicular effects of some quinolone members in rats", PHARMAC RES, 41(2), 2000, pp. 211-219
100. Casal, M; Ruiz, P; Herreras, A
     Study of the in vitro susceptibility of M-tuberculosis to ofloxacin in Spain
     INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
     
     M. Casal et al., "Study of the in vitro susceptibility of M-tuberculosis to ofloxacin in Spain", INT J TUBE, 4(6), 2000, pp. 588-591